Synthesis of 2-[18F]fluoroadenosine (2-[18F]FAD) as potential radiotracer for studying malignancies by PET

Andrew G. Horti; Hayden T. Ravert; William B. Mathews; Edward H. Abraham; Richard L. Wahl; Robert F. Dannals

doi:10.1002/jlcr.1097

Synthesis of 2-[¹⁸F]fluoroadenosine (2-[¹⁸F]FAD) as potential radiotracer for studying malignancies by PET

Andrew G. Horti, Hayden T. Ravert, William B. Mathews, Edward H. Abraham, Richard L. Wahl, Robert F. Dannals

School of Medicine

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

2-[¹⁸F]fluoroadenosine (2-[¹⁸F]FAD), a potential radioligand for assessment of adenylate metabolism, was synthesized by carrier-added and no-carrier-added procedures via nucleophilic radiofluorination of 2-fluoroadenosine and 2-iodoadenosine. The radiochemical yield, specific radioactivity and radiochemical purity of carrier-added and no-carrier-added 2-[¹⁸F]FAD were 5%, 22-30 mCi/μmol and 99%, and 0.5%, 1200-1700 mCi/μmol and 99%, respectively.

Original language	English (US)
Pages (from-to)	811-815
Number of pages	5
Journal	Journal of Labelled Compounds and Radiopharmaceuticals
Volume	49
Issue number	9
DOIs	https://doi.org/10.1002/jlcr.1097
State	Published - Aug 2006

Keywords

2-[F] fluoroadenosine
Adenylate metabolism
Cancer
F
Positron emission tomography

ASJC Scopus subject areas

Analytical Chemistry
Biochemistry
Radiology Nuclear Medicine and imaging
Drug Discovery
Spectroscopy
Organic Chemistry

Access to Document

10.1002/jlcr.1097

Cite this

@article{ffe0ef3ef6c74d04b6cf2171afa25ee5,

title = "Synthesis of 2-[18F]fluoroadenosine (2-[18F]FAD) as potential radiotracer for studying malignancies by PET",

abstract = "2-[18F]fluoroadenosine (2-[18F]FAD), a potential radioligand for assessment of adenylate metabolism, was synthesized by carrier-added and no-carrier-added procedures via nucleophilic radiofluorination of 2-fluoroadenosine and 2-iodoadenosine. The radiochemical yield, specific radioactivity and radiochemical purity of carrier-added and no-carrier-added 2-[18F]FAD were 5%, 22-30 mCi/μmol and 99%, and 0.5%, 1200-1700 mCi/μmol and 99%, respectively.",

keywords = "2-[F] fluoroadenosine, Adenylate metabolism, Cancer, F, Positron emission tomography",

author = "Horti, {Andrew G.} and Ravert, {Hayden T.} and Mathews, {William B.} and Abraham, {Edward H.} and Wahl, {Richard L.} and Dannals, {Robert F.}",

year = "2006",

month = aug,

doi = "10.1002/jlcr.1097",

language = "English (US)",

volume = "49",

pages = "811--815",

journal = "Journal of Labelled Compounds and Radiopharmaceuticals",

issn = "0362-4803",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Synthesis of 2-[18F]fluoroadenosine (2-[18F]FAD) as potential radiotracer for studying malignancies by PET

AU - Horti, Andrew G.

AU - Ravert, Hayden T.

AU - Mathews, William B.

AU - Abraham, Edward H.

AU - Wahl, Richard L.

AU - Dannals, Robert F.

PY - 2006/8

Y1 - 2006/8

N2 - 2-[18F]fluoroadenosine (2-[18F]FAD), a potential radioligand for assessment of adenylate metabolism, was synthesized by carrier-added and no-carrier-added procedures via nucleophilic radiofluorination of 2-fluoroadenosine and 2-iodoadenosine. The radiochemical yield, specific radioactivity and radiochemical purity of carrier-added and no-carrier-added 2-[18F]FAD were 5%, 22-30 mCi/μmol and 99%, and 0.5%, 1200-1700 mCi/μmol and 99%, respectively.

AB - 2-[18F]fluoroadenosine (2-[18F]FAD), a potential radioligand for assessment of adenylate metabolism, was synthesized by carrier-added and no-carrier-added procedures via nucleophilic radiofluorination of 2-fluoroadenosine and 2-iodoadenosine. The radiochemical yield, specific radioactivity and radiochemical purity of carrier-added and no-carrier-added 2-[18F]FAD were 5%, 22-30 mCi/μmol and 99%, and 0.5%, 1200-1700 mCi/μmol and 99%, respectively.

KW - 2-[F] fluoroadenosine

KW - Adenylate metabolism

KW - Cancer

KW - F

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=33748545928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748545928&partnerID=8YFLogxK

U2 - 10.1002/jlcr.1097

DO - 10.1002/jlcr.1097

M3 - Article

AN - SCOPUS:33748545928

SN - 0362-4803

VL - 49

SP - 811

EP - 815

JO - Journal of Labelled Compounds and Radiopharmaceuticals

JF - Journal of Labelled Compounds and Radiopharmaceuticals

IS - 9

ER -